Alseres Pharmaceuticals Inc (ALSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2008 | 12-2007 | 09-2007 | 06-2007 | 03-2007 | |
| Operating Expenses | 4,903 | 5,087 | 4,471 | 5,147 | 4,176 |
| Operating Income | -4,903 | -5,087 | -4,471 | -5,147 | -4,176 |
| Interest Expense | 459 | 439 | 328 | 187 | -77 |
| Other Income | 37 | 86 | 64 | 41 | 18 |
| Pre-tax Income | -5,326 | -5,439 | -4,735 | -5,293 | -4,081 |
| Net Income Continuous | -5,326 | -5,439 | -4,735 | -5,293 | -4,081 |
| Net Income | $-5,326 | $-5,439 | $-4,735 | $-5,293 | $-4,081 |
| EPS Basic Total Ops | -1,300.00 | -1,300.00 | -1,150.00 | -1,500.00 | -1,250.00 |
| EPS Basic Continuous Ops | -1,279.84 | -1,285.15 | -1,143.85 | -1,520.82 | -1,229.93 |
| EPS Diluted Total Ops | -1,300.00 | -1,300.00 | -1,150.00 | -1,500.00 | -1,250.00 |
| EPS Diluted Continuous Ops | -1,279.84 | -1,285.15 | -1,143.85 | -1,520.82 | -1,229.93 |
| EBITDA(a) | $-4,893 | $-5,076 | $-4,460 | $-5,116 | $-4,145 |